{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:06:33Z","timestamp":1770818793618,"version":"3.50.1"},"reference-count":98,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,12,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Patients with sickle cell disease (SCD) suffer from intense pain that can start during infancy and increase in severity throughout life, leading to hospitalization and poor quality of life. A unique feature of SCD is vaso-occlusive crises (VOCs) characterized by episodic, recurrent, and unpredictable episodes of acute pain. Microvascular obstruction during a VOC leads to impaired oxygen supply to the periphery and ischemia reperfusion injury, inflammation, oxidative stress, and endothelial dysfunction, all of which may perpetuate a noxious microenvironment leading to pain. In addition to episodic acute pain, patients with SCD also report chronic pain. Current treatment of moderate to severe pain in SCD is mostly reliant upon opioids; however, long-term use of opioids is associated with multiple side effects. This review presents up-to-date developments in our understanding of the pathobiology of pain in SCD. To help focus future research efforts, major gaps in knowledge are identified regarding how sickle pathobiology evokes pain, pathways specific to chronic and acute sickle pain, perception-based targets of \u201ctop-down\u201d mechanisms originating from the brain and neuromodulation, and how pain affects the sickle microenvironment and pathophysiology. This review also describes mechanism-based targets that may help develop novel therapeutic and\/or preventive strategies to ameliorate pain in SCD.<\/jats:p>","DOI":"10.1182\/asheducation-2017.1.546","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T22:13:11Z","timestamp":1555452791000},"page":"546-555","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":18,"title":["Targeting novel mechanisms of pain in sickle cell disease"],"prefix":"10.1182","volume":"2017","author":[{"given":"Huy","family":"Tran","sequence":"first","affiliation":[{"name":"Vascular Biology Center, Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihir","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of California San Diego, La Jolla, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalpna","family":"Gupta","sequence":"additional","affiliation":[{"name":"Vascular Biology Center, Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"18","key":"2019111704241289000_B1","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1182\/blood-2012-04-383430","article-title":"Sickle cell pain: a critical reappraisal","volume":"120","author":"Ballas","year":"2012","journal-title":"Blood"},{"key":"2019111704241289000_B2","volume-title":"Sickle cell pain","author":"Ballas","year":"2015"},{"key":"2019111704241289000_B3","unstructured":"Aich\n              A\n            , BeitzAJ, GuptaK. Mechanisms of pain in sickle cell disease. In: Pain and Common Chronic Complications. InTech; 2016. Available at: http:\/\/www.intechopen.com\/books\/sickle-cell-disease-pain-and-common-chronic-complications\/mechanisms-of-pain-in-sickle-cell-disease. Accessed May 28, 2017."},{"issue":"4537","key":"2019111704241289000_B4","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/178792a0","article-title":"A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin","volume":"178","author":"Ingram","year":"1956","journal-title":"Nature"},{"issue":"3","key":"2019111704241289000_B5","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1172\/JCI89741","article-title":"Intravascular hemolysis and the pathophysiology of sickle cell disease","volume":"127","author":"Kato","year":"2017","journal-title":"J Clin Invest"},{"issue":"16","key":"2019111704241289000_B6","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel","year":"2017","journal-title":"N Engl J Med"},{"issue":"20","key":"2019111704241289000_B7","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1182\/blood-2017-02-765891","article-title":"Treating sickle cell disease by targeting HbS polymerization","volume":"129","author":"Eaton","year":"2017","journal-title":"Blood"},{"issue":"10091","key":"2019111704241289000_B8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","article-title":"Sickle cell disease","volume":"390","author":"Ware","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"2019111704241289000_B9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pathol.2016.10.002","article-title":"Sickle cell disease in the older adult","volume":"49","author":"Thein","year":"2017","journal-title":"Pathology"},{"key":"2019111704241289000_B10","first-page":"189","article-title":"Anatomic lesions in sickle cell disease","volume-title":"Sickle Cell Disease: Diagnosis, Management, Education and Research","author":"Diggs","year":"1973"},{"issue":"5","key":"2019111704241289000_B11","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/ajh.23683","article-title":"Factors associated with survival in a contemporary adult sickle cell disease cohort","volume":"89","author":"Elmariah","year":"2014","journal-title":"Am J Hematol"},{"issue":"10","key":"2019111704241289000_B12","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1182\/blood-2016-05-716910","article-title":"Survival in adults with sickle cell disease in a high-income setting","volume":"128","author":"Gardner","year":"2016","journal-title":"Blood"},{"issue":"2","key":"2019111704241289000_B13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7326\/0003-4819-148-2-200801150-00004","article-title":"Daily assessment of pain in adults with sickle cell disease","volume":"148","author":"Smith","year":"2008","journal-title":"Ann Intern Med"},{"issue":"2","key":"2019111704241289000_B14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/35053509","article-title":"The molecular dynamics of pain control","volume":"2","author":"Hunt","year":"2001","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"2019111704241289000_B15","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1182\/blood-2010-01-260372","article-title":"Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids","volume":"116","author":"Kohli","year":"2010","journal-title":"Blood"},{"issue":"4","key":"2019111704241289000_B16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2141.2011.08977.x","article-title":"Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness","volume":"156","author":"Cain","year":"2011","journal-title":"Br J Haematol"},{"issue":"8","key":"2019111704241289000_B17","doi-asserted-by":"crossref","first-page":"e0160608","DOI":"10.1371\/journal.pone.0160608","article-title":"Comparative analysis of pain behaviours in humanized mouse models of sickle cell anemia","volume":"11","author":"Lei","year":"2016","journal-title":"PLoS One"},{"key":"2019111704241289000_B18","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/540154","article-title":"Morphine for the treatment of pain in sickle cell disease","author":"Gupta","year":"2015"},{"issue":"1","key":"2019111704241289000_B19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pain.2009.07.008","article-title":"Climatic and geographic temporal patterns of pain in the Multicenter Study of Hydroxyurea","volume":"146","author":"Smith","year":"2009","journal-title":"Pain"},{"issue":"1","key":"2019111704241289000_B20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ajh.23341","article-title":"Patients with sickle cell disease have increased sensitivity to cold and heat","volume":"88","author":"Brandow","year":"2012","journal-title":"Am J Hematol"},{"issue":"5","key":"2019111704241289000_B21","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jpain.2016.01.475","article-title":"An evaluation of central sensitization in patients with sickle cell disease","volume":"17","author":"Campbell","year":"2016","journal-title":"J Pain"},{"issue":"9","key":"2019111704241289000_B22","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/pbc.25574","article-title":"Early insights into the neurobiology of pain in sickle cell disease: aA systematic review of the literature","volume":"62","author":"Brandow","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"2019111704241289000_B23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/MPH.0000000000000214","article-title":"Sensory and thermal quantitative testing in children with sickle cell disease","volume":"37","author":"Jacob","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"issue":"12","key":"2019111704241289000_B24","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1182\/blood-2010-12-327429","article-title":"Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease","volume":"118","author":"Hillery","year":"2011","journal-title":"Blood"},{"issue":"3","key":"2019111704241289000_B25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000321791","article-title":"Plasma glial fibrillary acidic protein levels in a child with sickle cell disease and stroke","volume":"125","author":"Savage","year":"2011","journal-title":"Acta Haematol"},{"issue":"2","key":"2019111704241289000_B26","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.3324\/haematol.2015.137489","article-title":"Spinal glial activation and oxidative stress are alleviated by treatment with curcumin or coenzyme Q in sickle mice","volume":"101","author":"Valverde","year":"2015","journal-title":"Haematologica"},{"issue":"11","key":"2019111704241289000_B27","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1182\/blood-2013-04-498105","article-title":"Mast cell activation contributes to sickle cell pathobiology and pain in mice","volume":"122","author":"Vincent","year":"2013","journal-title":"Blood"},{"issue":"2","key":"2019111704241289000_B28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/bjh.14300","article-title":"Substance P is increased in patients with sickle cell disease and associated with haemolysis and hydroxycarbamide use","volume":"175","author":"Brandow","year":"2016","journal-title":"Br J Haematol"},{"issue":"9","key":"2019111704241289000_B29","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1182\/blood.V92.9.3148","article-title":"Serum levels of substance P are elevated in patients with sickle cell disease and increase further during vaso-occlusive crisis","volume":"92","author":"Michaels","year":"1998","journal-title":"Blood"},{"issue":"2","key":"2019111704241289000_B30","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/PAF.0b013e318187de71","article-title":"Fatal overdose due to prescription fentanyl patches in a patient with sickle cell\/beta-thalassemia and acute chest syndrome: a case report and review of the literature","volume":"30","author":"Biedrzycki","year":"2009","journal-title":"Am J Forensic Med Pathol"},{"issue":"23","key":"2019111704241289000_B31","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V126.23.986.986","article-title":"Characteristics and potential biomarkers for chronic pain in patients with sickle cell disease [abstract]","volume":"126","author":"Kuei","year":"2015","journal-title":"Blood"},{"issue":"3","key":"2019111704241289000_B32","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.neuron.2015.06.005","article-title":"Nociception, pain, negative moods, and behavior selection","volume":"87","author":"Baliki","year":"2015","journal-title":"Neuron"},{"issue":"2","key":"2019111704241289000_B33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","article-title":"Cellular and molecular mechanisms of pain","volume":"139","author":"Basbaum","year":"2009","journal-title":"Cell"},{"key":"2019111704241289000_B34","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1097\/j.pain.0000000000000798","article-title":"Reward, motivation, and emotion of pain and its relief","volume":"158","author":"Porreca","year":"2017","journal-title":"Pain"},{"issue":"4","key":"2019111704241289000_B35","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejpain.2004.11.001","article-title":"Human brain mechanisms of pain perception and regulation in health and disease","volume":"9","author":"Apkarian","year":"2005","journal-title":"Eur J Pain"},{"issue":"1","key":"2019111704241289000_B36","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1089\/jayao.2016.0013","article-title":"Clinical case report: yoga for fatigue in five young adult survivors of childhood cancer","volume":"6","author":"Evans","year":"2017","journal-title":"J Adolesc Young Adult Oncol"},{"key":"2019111704241289000_B37","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2147\/JPR.S131859","article-title":"The effect of hypnosis on pain and peripheral blood flow in sickle-cell disease: a pilot study","volume":"10","author":"Bhatt","year":"2017","journal-title":"J Pain Res"},{"key":"2019111704241289000_B38","author":"McClish","year":"2017"},{"key":"2019111704241289000_B39","unstructured":"National Heart, Lung, and Blood Institute. Evidence-based management of sickle cell disease: expert panel report, 2014. Available at: https:\/\/www.nhlbi.nih.gov\/sites\/www.nhlbi.nih.gov\/files\/sickle-cell-disease-report%20020816.pdf. Accessed 14 June 2017."},{"issue":"5","key":"2019111704241289000_B40","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jpain.2016.12.016","article-title":"AAPT diagnostic criteria for chronic sickle cell disease pain","volume":"18","author":"Dampier","year":"2017","journal-title":"J Pain"},{"issue":"6","key":"2019111704241289000_B41","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jpainsymman.2010.03.020","article-title":"Hydroxyurea and acute painful crises in sickle cell anemia: effects on hospital length of stay and opioid utilization during hospitalization, outpatient acute care contacts, and at home","volume":"40","author":"Ballas","year":"2010","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"2019111704241289000_B42","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5055\/jom.2015.0273","article-title":"Daily home opioid use in adults with sickle cell disease: the PiSCES project","volume":"11","author":"Smith","year":"2015","journal-title":"J Opioid Manag"},{"issue":"1","key":"2019111704241289000_B43","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/1535370214544275","article-title":"Sickle cell disease in mice is associated with sensitization of sensory nerve fibers","volume":"240","author":"Kenyon","year":"2014","journal-title":"Exp Biol Med (Maywood)"},{"issue":"4","key":"2019111704241289000_B44","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/j.pain.0000000000000104","article-title":"Sensitization of nociceptive spinal neurons contributes to pain in a transgenic model of sickle cell disease","volume":"156","author":"Cataldo","year":"2015","journal-title":"Pain"},{"issue":"9","key":"2019111704241289000_B45","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1097\/j.pain.0000000000000966","article-title":"Sensitization of C-fiber nociceptors in mice with sickle cell disease is decreased by local inhibition of anandamide hydrolysis","volume":"158","author":"Uhelski","year":"2017","journal-title":"Pain"},{"issue":"2","key":"2019111704241289000_B46","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12291-012-0277-9","article-title":"Hematological parameters and RBC TBARS level of Q 10 supplemented tribal sickle cell patients: a hospital based study","volume":"28","author":"Thakur","year":"2012","journal-title":"Indian J Clin Biochem"},{"issue":"11","key":"2019111704241289000_B47","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jpain.2015.07.005","article-title":"Frequency of hospitalizations for pain and association with altered brain network connectivity in sickle cell disease","volume":"16","author":"Darbari","year":"2015","journal-title":"J Pain"},{"key":"2019111704241289000_B48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nicl.2016.12.024","article-title":"Characterization of functional brain activity and connectivity using EEG and fMRI in patients with sickle cell disease","volume":"14","author":"Case","year":"2017","journal-title":"Neuroimage Clin"},{"issue":"4","key":"2019111704241289000_B49","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/bjh.13232","article-title":"Cognitive evoked potentials and neural networks are abnormal in children with sickle cell disease and not related to the degree of anaemia, pain and silent infarcts","volume":"169","author":"Colombatti","year":"2014","journal-title":"Br J Haematol"},{"issue":"3","key":"2019111704241289000_B50","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.pneurobio.2011.01.002","article-title":"The effect of pain on cognitive function: a review of clinical and preclinical research","volume":"93","author":"Moriarty","year":"2011","journal-title":"Prog Neurobiol"},{"issue":"1","key":"2019111704241289000_B51","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pscychresns.2015.04.005","article-title":"Brain venular pattern by 7T MRI correlates with memory and haemoglobin in sickle cell anaemia","volume":"233","author":"Novelli","year":"2015","journal-title":"Psychiatry Res"},{"issue":"5","key":"2019111704241289000_B52","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3324\/haematol.2015.136523","article-title":"Cannabinoid receptor-specific mechanisms to alleviate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation","volume":"101","author":"Vincent","year":"2015","journal-title":"Haematologica"},{"issue":"5","key":"2019111704241289000_B53","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jpain.2010.10.012","article-title":"Increased clearance of morphine in sickle cell disease: implications for pain management","volume":"12","author":"Darbari","year":"2011","journal-title":"J Pain"},{"key":"2019111704241289000_B54","first-page":"109","article-title":"Morphine promotes renal pathology in sickle mice","volume":"5","author":"Weber","year":"2012","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"3","key":"2019111704241289000_B55","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nm.2633","article-title":"Blockade of PDGFR-\u03b2 activation eliminates morphine analgesic tolerance","volume":"18","author":"Wang","year":"2012","journal-title":"Nat Med"},{"key":"2019111704241289000_B56","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1100\/tsw.2007.230","article-title":"Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward","volume":"7","author":"Hutchinson","year":"2007","journal-title":"Sci World J"},{"issue":"3","key":"2019111704241289000_B57","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1124\/pr.110.004135","article-title":"Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia","volume":"63","author":"Hutchinson","year":"2011","journal-title":"Pharmacol Rev"},{"issue":"5","key":"2019111704241289000_B58","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease","volume":"376","author":"Ataga","year":"2017","journal-title":"N Engl J Med"},{"issue":"22","key":"2019111704241289000_B59","doi-asserted-by":"crossref","first-page":"13875","DOI":"10.1074\/jbc.M115.642736","article-title":"Neutrophil elastase activates protease-activated receptor-2 (PAR2) and transient receptor potential vanilloid 4 (TRPV4) to cause inflammation and pain","volume":"290","author":"Zhao","year":"2015","journal-title":"J Biol Chem"},{"issue":"24","key":"2019111704241289000_B60","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2013-10-529982","article-title":"Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease","volume":"123","author":"Chen","year":"2014","journal-title":"Blood"},{"issue":"22","key":"2019111704241289000_B61","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V128.22.858.858","article-title":"Regulation of elastase by SerpinA3N contributes to pain in sickle cell disease [abstract]","volume":"128","author":"Aich","year":"2016","journal-title":"Blood"},{"issue":"3","key":"2019111704241289000_B62","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/jlb.66.3.411","article-title":"Neutrophil activation in sickle cell disease","volume":"66","author":"Lard","year":"1999","journal-title":"J Leukoc Biol"},{"issue":"11","key":"2019111704241289000_B63","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.3324\/haematol.2013.088021","article-title":"Nucleosomes and neutrophil activation in sickle cell disease painful crisis","volume":"98","author":"Schimmel","year":"2013","journal-title":"Haematologica"},{"issue":"5","key":"2019111704241289000_B64","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nm.3852","article-title":"The serine protease inhibitor SerpinA3N attenuates neuropathic pain by inhibiting T cell-derived leukocyte elastase","volume":"21","author":"Vicu\u00f1a","year":"2015","journal-title":"Nat Med"},{"issue":"12","key":"2019111704241289000_B65","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.pain.2014.05.030","article-title":"Cold hypersensitivity increases with age in mice with sickle cell disease","volume":"155","author":"Zappia","year":"2014","journal-title":"Pain"},{"issue":"11","key":"2019111704241289000_B66","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/ajh.20708","article-title":"Clinical response of patients with sickle cell anemia to cromolyn sodium nasal spray","volume":"81","author":"Karimi","year":"2006","journal-title":"Am J Hematol"},{"issue":"2","key":"2019111704241289000_B67","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2141.2011.08670.x","article-title":"Chronic myeloid leukaemia and sickle cell disease: could imatinib prevent vaso-occlusive crisis","volume":"155","author":"Stankovic Stojanovic","year":"2011","journal-title":"Br J Haematol"},{"issue":"1","key":"2019111704241289000_B68","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.celrep.2016.05.080","article-title":"Sustained elevated adenosine via ADORA2B promotes chronic pain through neuro-immune interaction","volume":"16","author":"Hu","year":"2016","journal-title":"Cell Reports"},{"key":"2019111704241289000_B69","author":"Wu","year":"2014"},{"issue":"10","key":"2019111704241289000_B70","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.3324\/haematol.2016.148106","article-title":"Genetic inactivation of calpain-1 attenuates pain sensitivity in a humanized mouse model of sickle cell disease","volume":"101","author":"Nwankwo","year":"2016","journal-title":"Haematologica"},{"issue":"3","key":"2019111704241289000_B71","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1046\/j.1471-4159.1997.69031006.x","article-title":"Neuronal nitric oxide synthase and calmodulin-dependent protein kinase IIalpha undergo neurotoxin-induced proteolysis","volume":"69","author":"Hajimohammadreza","year":"1997","journal-title":"J Neurochem"},{"issue":"12","key":"2019111704241289000_B72","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1097\/j.pain.0000000000000704","article-title":"CaMKII\u03b1 underlies spontaneous and evoked pain behaviors in Berkeley sickle cell transgenic mice","volume":"157","author":"He","year":"2016","journal-title":"Pain"},{"issue":"27","key":"2019111704241289000_B73","doi-asserted-by":"crossref","first-page":"11002","DOI":"10.1523\/JNEUROSCI.1785-13.2013","article-title":"Role of nociceptor \u03b1CaMKII in transition from acute to chronic pain (hyperalgesic priming) in male and female rats","volume":"33","author":"Ferrari","year":"2013","journal-title":"J Neurosci"},{"key":"2019111704241289000_B74","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ejphar.2013.10.062","article-title":"Mechanism-driven phase I translational study of trifluoperazine in adults with sickle cell disease","volume":"723","author":"Molokie","year":"2014","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"2019111704241289000_B75","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000464288","article-title":"Downregulations of CD36 and Calpain-1, inflammation, and atherosclerosis by simvastatin in apolipoprotein E knockout mice","volume":"54","author":"Yin","year":"2017","journal-title":"J Vasc Res"},{"issue":"1","key":"2019111704241289000_B76","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1046\/j.1523-1755.2003.00718.x","article-title":"Extracellular signal-regulated kinase inhibition by statins inhibits neutrophil activation by ANCA","volume":"63","author":"Choi","year":"2003","journal-title":"Kidney Int"},{"issue":"4","key":"2019111704241289000_B77","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/bjh.14580","article-title":"Simvastatin reduces vaso-occlusive pain in sickle cell anaemia: a pilot efficacy trial","volume":"177","author":"Hoppe","year":"2017","journal-title":"Br J Haematol"},{"issue":"19","key":"2019111704241289000_B78","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1182\/bloodadvances.2017007211","article-title":"Pharmacotherapeutical strategies in the prevention of acute, vaso-occlusive pain in sickle cell disease: a systematic review","volume":"1","author":"Sins","year":"2017","journal-title":"Blood Adv"},{"issue":"6","key":"2019111704241289000_B79","doi-asserted-by":"crossref","first-page":"341","DOI":"10.5055\/jom.2009.0034","article-title":"The analgesic potential of cannabinoids","volume":"5","author":"Elikkottil","year":"2009","journal-title":"J Opioid Manag"},{"issue":"12","key":"2019111704241289000_B80","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3324\/haematol.2015.128736","article-title":"Small-molecule nociceptin receptor agonist ameliorates mast cell activation and pain in sickle mice","volume":"100","author":"Vang","year":"2015","journal-title":"Haematologica"},{"issue":"1","key":"2019111704241289000_B81","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/jcpt.12461","article-title":"Cebranopadol: novel dual opioid\/NOP receptor agonist analgesic","volume":"42","author":"Raffa","year":"2016","journal-title":"J Clin Pharm Ther"},{"issue":"9757","key":"2019111704241289000_B82","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"issue":"6","key":"2019111704241289000_B83","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00043426-200011000-00009","article-title":"Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome","volume":"22","author":"Morris","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"2019111704241289000_B84","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1046\/j.1365-2141.2000.02403.x","article-title":"Arginine therapy: a novel strategy to induce nitric oxide production in sickle cell disease","volume":"111","author":"Morris","year":"2000","journal-title":"Br J Haematol"},{"issue":"9","key":"2019111704241289000_B85","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3324\/haematol.2013.086637","article-title":"A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes","volume":"98","author":"Morris","year":"2013","journal-title":"Haematologica"},{"issue":"6","key":"2019111704241289000_B86","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1182\/blood-2014-12-616250","article-title":"Acute hemolytic vascular inflammatory processes are prevented by nitric oxide replacement or a single dose of hydroxyurea","volume":"126","author":"Almeida","year":"2015","journal-title":"Blood"},{"key":"2019111704241289000_B87","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-3-662-46450-2_6","article-title":"Nitric oxide-mediated pain processing in the spinal cord","volume":"227","author":"Schmidtko","year":"2015","journal-title":"Handb Exp Pharmacol"},{"issue":"9","key":"2019111704241289000_B88","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/jama.2011.235","article-title":"Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial","volume":"305","author":"Gladwin","year":"2011","journal-title":"JAMA"},{"issue":"4","key":"2019111704241289000_B89","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood-2010-09-306167","article-title":"Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity","volume":"118","author":"Machado","year":"2011","journal-title":"Blood"},{"issue":"4","key":"2019111704241289000_B90","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bbagrm.2017.01.014","article-title":"Epigenetic interplay at the \u03b2-globin locus","volume":"1860","author":"Lee","year":"2017","journal-title":"Biochim Biophys Acta"},{"issue":"19","key":"2019111704241289000_B91","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1128\/MCB.00714-14","article-title":"Fetal globin gene repressors as drug targets for molecular therapies to treat the \u03b2-globinopathies","volume":"34","author":"Suzuki","year":"2014","journal-title":"Mol Cell Biol"},{"issue":"4","key":"2019111704241289000_B92","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.bcmd.2015.08.001","article-title":"Rapamycin increases fetal hemoglobin and ameliorates the nociception phenotype in sickle cell mice","volume":"55","author":"Khaibullina","year":"2015","journal-title":"Blood Cells Mol Dis"},{"issue":"3","key":"2019111704241289000_B93","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/bjh.14057","article-title":"mTOR inhibition improves anaemia and reduces organ damage in a murine model of sickle cell disease","volume":"174","author":"Wang","year":"2016","journal-title":"Br J Haematol"},{"issue":"February","key":"2019111704241289000_B94","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.exphem.2017.02.003","article-title":"Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell disease","volume":"50","author":"Jagadeeswaran","year":"2017","journal-title":"Exp Hematol"},{"key":"2019111704241289000_B95","doi-asserted-by":"crossref","first-page":"j1284","DOI":"10.1136\/bmj.j1284","article-title":"Management of chronic pain using complementary and integrative medicine","volume":"357","author":"Chen","year":"2017","journal-title":"BMJ"},{"key":"2019111704241289000_B96","doi-asserted-by":"crossref","first-page":"34493","DOI":"10.1038\/srep34493","article-title":"Electroacupuncture in conscious free-moving mice reduces pain by ameliorating peripheral and central nociceptive mechanisms","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"key":"2019111704241289000_B97","article-title":"Individuals with sickle cell disease have a significantly greater vasoconstriction response to thermal pain than controls and have significant vasoconstriction in response to anticipation of pain [published online ahead of print 13 July 2017]","author":"Khaleel","journal-title":"Am J Hematol"},{"issue":"5","key":"2019111704241289000_B98","doi-asserted-by":"crossref","first-page":"e0178353","DOI":"10.1371\/journal.pone.0178353","article-title":"Biophysical markers of the peripheral vasoconstriction response to pain in sickle cell disease","volume":"12","author":"Chalacheva","year":"2017","journal-title":"PLoS One"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2017\/1\/546\/1249713\/hem00075.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2017\/1\/546\/1249713\/hem00075.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T09:25:01Z","timestamp":1573982701000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2017\/1\/546\/21069\/Targeting-novel-mechanisms-of-pain-in-sickle-cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,8]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12,8]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2017.1.546","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,8]]}}}